Page 1447 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

2 References

25. MacIsaac RJ, Lee LY, McNeil KJ, Tsalamandris C, Jerums G. effects of treatment with insulin and intravenous fluids and
Influence of age on the presentation and outcome of aci- effects of bumetanide. Diabetes. 2010;59(3):702-709.
dotic and hyperosmolar diabetic emergencies. Intern Med J. 43. Franklin B, Liu J, Ginsberg-Fellner F. Cerebral edema and
2002;32(8):379-385. ophthalmoplegia reversed by mannitol in a new case of insulin-
26. Hamblin PS, Topliss DJ, Chosich N, Lording DW, Stockigt JR. dependent diabetes mellitus. Pediatrics. 1982;69(1):87-90.
Deaths associated with diabetic ketoacidosis and hyperosmolar 44. Roberts MD, Slover RH, Chase HP. Diabetic ketoacidosis with
coma. 1973-1988. Med J Aust. 1989;151(8):439, 441-442, 444. intracerebral complications. Pediatr Diabetes. 2001;2(3):109-114.
27. Malone ML, Gennis V, Goodwin JS. Characteristics of diabetic 45. Kamat P, Vats A, Gross M, Checchia PA. Use of hypertonic
ketoacidosis in older versus younger adults. J Am Geriatr Soc. saline for the treatment of altered mental status associated with
1992;40(11):1100-1104. diabetic ketoacidosis. Pediatr Crit Care Med. 2003;4(2):239-242.
28. White NH. Diabetic ketoacidosis in children. Endocrinol Metab 46. Hasler WL, Soudah HC, Dulai G, Owyang C. Mediation of
Clin North Am. 2000;29(4):657-682. hyperglycemia-evoked gastric slow-wave dysrhythmias by endog-
29. Wolfsdorf J, Glaser N, Sperling MA; American Diabetes enous prostaglandins. Gastroenterology. 1995;108(3):727-736.
Association. Diabetic ketoacidosis in infants, children, and 47. Horowitz M, Harding PE, Maddox AF, et al. Gastric and
adolescents: a consensus statement from the American Diabetes oesophageal emptying in patients with Type 2 (non-insulin-
Association. 2006;29:1150-1159. dependent) diabetes mellitus. Diabetologia. 1989;32(3):151-159.
30. Wagner A, Risse A, Brill HL, et al. Therapy of severe diabetic 48. McLaren EH, Cullen DR, Brown MJ. Coagulation abnor-
ketoacidosis. Zero-mortality under very-low-dose insulin appli- malities in diabetic coma before and 24 hours after treatment.
cation. Diabetes Care. 1999;22(5):674-677. Diabetologia. 1979;17(6):345-349.
31. Vanelli M, Chiari G, Ghizzoni L, Costi G, Giacalone T, Chiarelli F. 49. Small M, Alzaid A, MacCuish AC. Diabetic hyperosmolar non-
Effectiveness of a prevention program for diabetic ketoacidosis ketotic decompensation. Q J Med. 1988;66(251):251-257.
in children: an 8-year study in schools and private practices. 50. Mylotte D, Kavanagh GF, Peace AJ, et al. Platelet reactivity in
Diabetes Care. 1999;22(1):7-9. type 2 diabetes mellitus: a comparative analysis with survivors
32. Vanelli M, Chiari G, Lacava S, Iovane B. Campaign for diabetic of myocardial infarction and the role of glycaemic control.
ketoacidosis prevention still effective 8 years later. Diabetes Platelets. 2012;23(6):439-446.
Care. 2007;30(4):e12. 51. Hayden MR, Tyagi SC, Kerklo MM, Nicolls MR. Type 2 diabetes
33. Marcin JP, Glaser N, Barnett P, et al. Factors associated with mellitus as a conformational disease. JOP. 2005;6(4):287-302.
adverse outcomes in children with diabetic ketoacidosis-related 52. Hernández-Espinosa D, Ordóñez A, Miñano A, Martínez-
cerebral edema. J Pediatr. 2002;141(6):793-797. Martínez I, Vicente V, Corral J. Hyperglycaemia impairs anti-
34. Krane EJ, Rockoff MA, Wallman JK, Wolfsdorf JI. Subclinical thrombin secretion: possible contribution to the thrombotic
brain swelling in children during treatment of diabetic ketoaci- risk of diabetes. Thromb Res. 2009;124(4):483-489.
dosis. N Engl J Med. 1985;312(18):1147-1151. 53. Keenan CR, Murin S, White RH. High risk for venous throm-
35. Muir AB, Quisling RG, Yang MCK, Rosenbloom AL. Cerebral boembolism in diabetics with hyperosmolar state: comparison
edema in childhood diabetic ketoacidosis: natural history, with other acute medical illnesses. J Thromb Haemost. 2007;
radiographic findings, and early identification. Diabetes Care. 5(6):1185-1190.
2004;27(7):1541-1546. 54. Kian K, Eiger G. Anticoagulant therapy in hyperosmolar non-
36. Lawrence SE, Cummings EA, Gaboury I, Daneman D. ketotic diabetic coma. Diabet Med. 2003;20(7):603.
Population-based study of incidence and risk factors for 55. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and
cerebral edema in pediatric diabetic ketoacidosis. J Pediatr. outcome of zygomycosis: a review of 929 reported cases. Clin
2005;146(5):688-692. Infect Dis. 2005;41(5):634-653.
37. Edge JA, Hawkins MM, Winter DL, Dunger DB. The risk and 56. Yohai RA, Bullock JD, Aziz AA, Markert RJ. Survival fac-
outcome of cerebral oedema developing during diabetic keto- tors in rhino-orbital-cerebral mucormycosis. Surv Ophthalmol.
acidosis. Arch Dis Child. 2001;85(1):16-22. 1994;39(1):3-22.
38. Hammond P, Wallis S. Cerebral oedema in diabetic ketoacido- 57. Powner D, Snyder JV, Grenvik A. Altered pulmonary capillary
sis. BMJ. 1992;305(6847):203-204. permeability complicating recovery from diabetic ketoacidosis.
39. Fein IA, Rachow EC, Sprung CL, Grodman R. Relation of col- Chest. 1975;68(2):253-256.
loid osmotic pressure to arterial hypoxemia and cerebral edema 58. Savage MW, Dhatariya KK, Kilvert A, et al. Joint British
during crystalloid volume loading of patients with diabetic Diabetes Societies guideline for the management of diabetic
ketoacidosis. Ann Intern Med. 1982;96(5):570-575. ketoacidosis. Diabet Med. 2011;28(5):508-515.
40. Abbott NJ. Inflammatory mediators and modulation of blood- 59. Huang C-L, Kuo E. Mechanism of hypokalemia in magnesium
brain barrier permeability. Cell Mol Neurobiol. 2000;20(2):131-147. deficiency. J Am Soc Nephrol. 2007;18(10):2649-2652.
41. Glaser N, Ngo C, Anderson S, Yuen N, Trifu A, O’Donnell M. 60. Murthy K, Harrington JT, Siegel RD. Profound hypokalemia
Effects of hyperglycemia and effects of ketosis on cerebral per- in diabetic ketoacidosis: a therapeutic challenge. Endocr Pract.
fusion, cerebral water distribution, and cerebral metabolism. 2005;11(5):331-334.
Diabetes. 2012;61(7):1831-1837. 61. Fisher JN, Kitabchi AE. A randomized study of phosphate ther-
42. Glaser N, Yuen N, Anderson SE, Tancredi DJ, O’Donnell ME. apy in the treatment of diabetic ketoacidosis. J Clin Endocrinol
Cerebral metabolic alterations in rats with diabetic ketoacidosis: Metab. 1983;57(1):177-180.

Section08-O-Ref.indd 2 12/10/2014 6:08:11 PM